Verified email-pattern data for Gene Bio-Systems is currently limited. You can still use the company insights and contact sections below.
We are coming with a portfolio of more than 45 products & growing addressing the most demanding requests for Middle East.
Company Details
- Founded
- -
- Address
- Giza . 6 October, Address: Block 140 3rd Industrial Zone -6 October City -Giza - Egypt,egypt
- Industry
- Biotechnology Research
- Website
- https://www.gene-biosystems.com/
- Keywords
- life-genetics egypt.
- HQ
- Giza
Gene Bio-Systems Questions
Gene Bio-systems's website is https://www.gene-biosystems.com/
Gene Bio-systems's LinkedIn profile is https://eg.linkedin.com/company/gene-bio-systems
Gene Bio-systems's industry is
Biotechnology Research
Gene Bio-systems's top competitors are
Omicsense,
Gene Lab,
Nora-Key Solutions,
Genelab Ghana,
Life-Genetics Egypt,
Institute Of Biochemistry Molecular Biology And Biotechnology,
ُelbrishy Design House,
Genebio Systems, Inc.,
Genelab,
Gene Care.
Gene Bio-systems's categories are Biotechnology Research
Gene Bio-systems's founding year is 2018
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.